HCPCS Level II J0585: OnabotulinumtoxinA Injection, 1 Unit
HCPCS Level II code J0585 denotes a single unit of onabotulinumtoxinA supplied for injection. This code is used to bill the drug component of botulinum toxin therapy, which is commonly applied in treating dystonias, spasticity-related conditions, blepharospasm, and other movement disorders; its proper coding affects medication cost reporting and care delivery metrics nationwide. Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what J0585 represents clinically and administratively, guidance on typical settings of service, and context on related procedure codes used for chemodenervation procedures. The publication outlines common diagnoses associated with onabotulinumtoxinA use, relevant practitioner taxonomies that typically bill for these services, and links to related CPT and HCPCS procedure codes for chemodenervation of specific anatomical sites. The report also summarizes common modifiers observed in billing scenarios and highlights areas where policy or coverage nuances commonly arise across major payers. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for hcpcs J0585 policy alerts
Get alerted when payer policies referencing J0585 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code J0585 represents an injectable medication product, described as Injection, onabotulinumtoxina, 1 unit. The service type is drug administration (botulinum toxin product) delivered via injection. The typical site of service is outpatient clinic or physician office, where specialists administer onabotulinumtoxinA for neuromuscular and movement disorder indications.
National Reimbursement Benchmarks
National commercial rates for J0585 center on a BUCA average commercial rate of $123.30, with individual commercial carriers clustering below and above that level. Blue Cross Blue Shield shows very tight dispersion (P75–P25 = $0.80), Cigna is similarly constrained (P75–P25 = $1.50), and UnitedHealth Group is narrow as well (P75–P25 = $0.40), indicating consistent contracted pricing among those carriers. Aetna exhibits extreme spread driven by outliers (P75–P25 = $1,351.20), reflecting substantial variability in negotiated highs versus lows across markets.
Mean and median differentials highlight concentration versus skew: Blue Cross Blue Shield, Cigna, and UnitedHealth Group have means near their medians, consistent with symmetric distributions, while Aetna’s mean ($820.60) far exceeds its median ($375.00), signaling a right-skewed distribution. The BUCA mean ($123.30) sits between the tight regional carriers and the high-variance Aetna, representing an average commercial benchmark for comparison.